Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s footer shows an updated revision/version number, indicating a site or interface release. No change to the study details or content sections (e.g., objectives, eligibility, interventions, or outcomes) is implied by this update.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision history updated to v3.5.0, replacing v3.4.3. This appears to be a backend or content-management update rather than a modification to study content.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange Detected- Version updated from v3.4.1 to v3.4.2. No user-facing content or functionality changes observed.SummaryDifference0.0%

- Check96 days agoChange DetectedUpdated site revision from v3.4.0 to v3.4.1. This appears to be a minor internal update with no visible changes to the study details or navigation.SummaryDifference0.0%

- Check110 days agoChange DetectedUI and metadata label updates include glossary toggles (Show glossary / Hide glossary) and revised fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), with older labels replaced (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.